Hydrogenated polyisobutene, Diisostearyl malate, Petrolatum, Microcrystalline wax,Ethylhexyl Salicylate, Ethylhexyl Triazone, Diethylhexyl Butamido Triazone, Zinc Oxide, C12-15 Alkyl Benzoate, Isostearic Acid, Polyhydroxystearic acid, Butyrospermum parkii butter, Avocado butter, Cocoa butter, Olive oil, Caprylic/capric triglyceride, Bis-behenyl/isostearyl/phytosteryl dimer dilinoleyl dimer dilinoleate, Jojoba oil, Argan oil, Sorbitan Olivate, Castor oil, Ethylene/propylene/styrene copolymer, Candelilla wax Euphorbia cerifera wax, Bees wax, Dextrin palmitate, Squalane, Punica granatum seed oil, Glycerin, Butylene glycol, Kojic acid dipalmitate, Saffron extract, Lauryl Laurate, Silica dimethyl silylate, Tocopheryl Acetate, Olea Europaea Fruit Extract, Olea Europaea Fruit Oil, Olea EuropaeaLeaf Extract, Oligopeptide-1, Butylene/ethylene/styrene copolymer, Caprylyl methicone, Hyaluronic acid, Saffron oil
NAD+ is a critical component of the electron transport chain, where it facilitates the transfer of electrons and the production of ATP
2005a;28(8):105671
Older GLP-1 receptor agonists such as exenatide and liraglutide have previously shown modest promise in people with schizophrenia, but their effects have been relatively limited and side effects were common
Gradual dose escalation can help minimize GI symptoms like nausea or abdominal pain
